Corrigendum to “Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis” [Int. Immunopharmacol. 131 (2024) 111826] (International Immunopharmacology (2024) 131, (S1567576924003448), (10.1016/j.intimp.2024.111826))
Artigo Académico